Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial Cancer
NCT04458402 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2025-12-18
Summary
Studying adjuvant hypofractionated whole pelvis radiation therapy in Endometrial Cancer.
Conditions
Interventions
- RADIATION
-
Hypofractionated WPRT
Cohort 1: 41.25 Gy in 15 fx Cohort 1: 38 Gy in 10 fx
Sponsors & Collaborators
-
Teresa Meier
lead OTHER
Principal Investigators
-
Teresa Meier, MD · University of Cincinnati
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-04
- Primary Completion
- 2025-01-30
- Completion
- 2025-04-17
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery
NCT00002807 ·Status: COMPLETED ·Phase: NA
-
Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy
NCT00508703 ·Status: COMPLETED
-
Stereotactic Pelvic Adjuvant Radiation TherApy in Cancers of the UteruS
NCT04866394 ·Status: UNKNOWN ·Phase: NA
-
Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer
NCT01180504 ·Status: UNKNOWN ·Phase: PHASE2
-
Adjuvant Stereotactic Pelvic Irradiation in Endometrial Cancer
NCT04235179 ·Status: RECRUITING ·Phase: PHASE2
-
Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
NCT04592887 ·Status: COMPLETED ·Phase: NA
-
Pelvic Cancer Registry for Online Adapted Radiotherapy
NCT06185062 ·Status: RECRUITING
-
Adaptive Radiotherapy in Patients With Gynecological Tumors
NCT06230549 ·Status: RECRUITING ·Phase: NA
-
Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix
NCT01600040 ·Status: COMPLETED ·Phase: NA
-
2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy
NCT02091050 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy in Uterine Cancer: Dosimetry Analysis, Clinical Implication, and Survival Analysis
NCT04251676 ·Status: UNKNOWN
-
MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer
NCT02582931 ·Status: COMPLETED ·Phase: PHASE1
-
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer
NCT01367301 ·Status: TERMINATED ·Phase: NA
-
Bone Toxicity Following Pelvic Radiotherapy
NCT04555317 ·Status: UNKNOWN ·Phase: NA
-
Radiotherapy Treatments for Neoplasms in the Abdominal-pelvic Region
NCT06335238 ·Status: RECRUITING
-
Prophylactic Irradiation of the Para-Aortic Lymph Nodes in Locally Advanced Uterine Cervical Cancer
NCT00980759 ·Status: UNKNOWN ·Phase: NA
-
Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer
NCT07116213 ·Status: RECRUITING ·Phase: NA
-
Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease
NCT05115331 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer
NCT00003045 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated Radiotherapy in Breast Cancer
NCT03167359 ·Status: COMPLETED ·Phase: NA
-
Adjuvant Protontherapy of Cervical and Endometrial Carcinomas
NCT03184350 ·Status: UNKNOWN ·Phase: NA
-
Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis
NCT01757717 ·Status: COMPLETED ·Phase: NA
-
Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet
NCT02902107 ·Status: COMPLETED ·Phase: PHASE1
-
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
NCT05640999 ·Status: RECRUITING ·Phase: PHASE2
-
An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical Cancer
NCT01514955 ·Status: WITHDRAWN ·Phase: PHASE1